Recent findings suggest that morbid obesity does not necessarily result in more severe symptoms, such as obstructive sleep apne and dyslipidemia, as well as decreased quality of life, when compared to morbidly obese who underwent weight-loss surgery. However, obese people who were satisfied with more extreme obesity-induced symptoms may not be content with their symptoms. For this purpose, obesity-surgery should not be considered as only cure for obese symptoms. Recent findings imply that weight control, including weight loss, is a necessary prerequisite for obese patients with symptoms to be satisfied.
Patients are treated more often with medical therapy than with surgery, while obesity is commoner in whites than in Asian Indians. Weight loss occurs less in Asians than in whites and Hispanics. The majority of obese patients in South-East Asians present for treatment in the secondary care setting and thus there are few inpatient services. We propose that all physicians should be aware of the common methods of treatment for obesity.
There is growing evidence that overweight and obesity are associated with an increased risk of cardiovascular disease, hypertension, type 2 diabetes, osteoarthritis, asthma, sleep apnea, and other chronic illnesses. In addition, these associations appear to be most pronounced in men and may be partially genetically determined. In a recent study, findings reinforces the importance of obesity and overweight as risk factors for chronic diseases.
Obesity and morbidity are frequently associated and are closely linked to many common disorders and diseases. As morbid obesity is more strongly and directly associated with diabetes, hypertension, heart disease, stroke and cancer, there is a need to develop targeted obesity prevention and treatment programmes.
While overall obesity has declined over time, there is currently an increasing prevalence of moderate hypercholesterolemia and of diabetes and other comorbidities. In the past 30 years, the prevalence of obesity and obesity-related comorbidities have increased.
Signs of obesity range from fatigue and difficulty in standing up to loss of appetite, weight loss, difficulty in swallowing, a small waist, and increased abdominal fat. Morbid obesity can be defined as having two or more of the obesity signs outlined here and a high fasting serum triglyceride level.
There is currently no cure for HPV. The treatment must be taken under the condition of the patients' health. For example, overweight individuals should take an antiviral drug in an initial treatment phase to slow down the tumor growth, and a medication for lowering the body weight in addition to maintenance therapy. Physicians should also check blood levels of cancer markers and take blood measurements under a proper schedule. For patients with high levels of lipids in their blood, doctors should take care to diminish their intake of triglycerides, fatty foods, and other kinds of fats.
There was no clear risk of complications with any of the treatments; however, the results of the study are expected to help the health professionals assess treatment for morbid obesity and assist in treating their patients with care and advice to ensure patient compliance at all times.
Patients with obesity or morbid obesity often have comorbidities that can be treated with medications. For example, weight loss alone is not an effective measure for treatment of hypertension or elevated cholesterol levels. Physicians using the ADA and the ACC/AHA recommendations would not treat patients with obesity solely for weight loss. Further research is needed to determine whether specific clinical management strategies have a positive impact on patient-reported health and quality of life and if they are cost-effective.
About 45% of patients in this study received some form of weight-loss treatment. Weight-loss interventions could be combined with other treatments, however, further investigation is warranted. Obesity remains one of the major challenges for many medical specialties.
Treatment of obesity with weight loss and a low-fat diet may improve physical function and some aspects of health related QoL in a patient with morbid obesity. However, the degree of improvement was modest and most aspects of health related QoL were not improved. Weight reduction may be an important component of more comprehensive treatment for morbid obesity.
Obesity has been a challenge in the health care system since its epidemic in the late 1970s, and this challenge has persisted during these recent years. However, obesity remains a major problem in the health care system. There are currently few new therapies available to treat obesity, morbid, for this problem.